CVS Health Co. (NYSE:CVS) Shares Sold by Cerity Partners LLC

Cerity Partners LLC trimmed its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 16.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 518,731 shares of the pharmacy operator's stock after selling 99,249 shares during the period. Cerity Partners LLC's holdings in CVS Health were worth $24,028,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Arete Wealth Advisors LLC acquired a new stake in CVS Health during the third quarter worth approximately $1,369,000. Morse Asset Management Inc acquired a new stake in CVS Health during the 3rd quarter worth $409,000. Wellington Management Group LLP lifted its position in CVS Health by 6.2% in the third quarter. Wellington Management Group LLP now owns 224,248 shares of the pharmacy operator's stock valued at $14,101,000 after acquiring an additional 13,120 shares during the last quarter. iA Global Asset Management Inc. boosted its stake in CVS Health by 15.6% in the third quarter. iA Global Asset Management Inc. now owns 8,156 shares of the pharmacy operator's stock valued at $513,000 after acquiring an additional 1,103 shares in the last quarter. Finally, Glass Jacobson Investment Advisors llc grew its holdings in shares of CVS Health by 26.8% during the third quarter. Glass Jacobson Investment Advisors llc now owns 1,220 shares of the pharmacy operator's stock worth $77,000 after purchasing an additional 258 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS Health stock traded down $0.07 during trading hours on Monday, hitting $69.44. The stock had a trading volume of 2,104,017 shares, compared to its average volume of 11,729,107. The stock has a market capitalization of $87.55 billion, a price-to-earnings ratio of 18.97, a PEG ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $71.66. The stock's fifty day moving average is $65.10 and its two-hundred day moving average is $58.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.83%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

Analyst Ratings Changes

Several analysts have recently weighed in on CVS shares. Evercore ISI upped their target price on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday, January 27th. Wolfe Research increased their price objective on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a report on Tuesday, February 11th. StockNews.com raised shares of CVS Health from a "sell" rating to a "hold" rating in a report on Thursday, February 13th. Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $55.00 to $75.00 in a research report on Thursday, February 13th. Finally, Mizuho lifted their price objective on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $71.28.

Insider Transactions at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.24% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.